BLOOD PRODUCTS DERIVED FROM PLASMA OR RECOMBINANT DNA TECHNOLOGY; ALL OF THE AFORESAID GOODS BEING USED FOR THE TREATMENT OF HEMOPHILIA AND/OR BLOOD OR BLEEDING DISORDERS